Cutler Group’s Cellebrite CLBT Stock Holding History

Cutler Group’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,900	Closed	-$2K	–	5385
2021 Q4	$2K	Sell	30,900 -81,800	-73%	-$770K	﹤0.01%	4678
2021 Q3	$32K	Buy	+112,700	New	+$1.18M	﹤0.01%	2911

Other funds holding CLBT

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cutler Group's CLBT Position: Q4 2022 in Review

Cutler Group sold out of Cellebrite (CLBT) in Q4 2022, closing a stake of 368 shares — an estimated $1K sold.

Cutler Group first reported a position in CLBT in Q3 2021 and held it in 5 quarters. The position peaked at $66K in Q3 2021. 52 funds tracked by Wall St. Rank hold CLBT as of Q4 2022.

Cutler Group reported no remaining Cellebrite position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 368 Cellebrite shares in Q4 2022, an estimated $1K.
Cutler Group first reported a position in Cellebrite in Q3 2021 and held it in 5 quarters.
Cutler Group's Cellebrite position peaked at $66K in Q3 2021.
52 funds tracked by Wall St. Rank held Cellebrite as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.